FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2331765972> ?p ?o ?g. }

• W2331765972 endingPage "668" @default.
• W2331765972 startingPage "667.3" @default.
• W2331765972 abstract "<h3>Background</h3> EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis (RA) states that inflammation seen on ultrasound (US) is considered to be useful in monitoring disease activity, however, the timing of US assessments and the evaluation system still remain to be elucidated in daily clinical practice. <h3>Objectives</h3> We have evaluated the therapeutic responsiveness of US variables in RA patients treated with biologic DMARDs in relation with clinical disease activity. <h3>Methods</h3> The consecutive forty RA patients treated with biologic DMARDs, whose median disease duration 45 months and DAS28-ESR 5.34 at entry, were retrospectively recruited in the present study. Patients gave their informed consent to be subjected to the protocol. Articular synovitis was assessed by US at the 22 joints including bilateral wrist joints, 1-5th metacarpophalangeal (MCP) joints, interphalangeal joints and 2nd - 5th proximal interphalangeal (PIP) joints. Each joint was scored for gray scale (GS) as well as power Doppler (PD) on the scale from 0 to 3 and the sum of GS or PD scores was considered as US disease activity. We have investigated the correlations of the changes of US disease activity at 3 months with DAS28-EULAR response criteria at 6 months. The changes of US disease activity was set as % changes of GS or PD scores at 3 months. <h3>Results</h3> As a whole, GS scores as well as PD scores were significantly decreased by biologic DMARDs at 3 months (p<0.0001, Wilcoxon9s signed rank test). Accordingly, the % changes of both GS and PD scores at 3 months were significantly higher in moderate and good responders at 6 months than no responders (p<0.0001, Mann-Whitney9s U test). Regarding to individual sites, it is interesting to note that the % changes of PD scores of wrist joints or MCP joints (sum of 1-5th MCP joints) at 3 months are most predictive toward moderate and good responders at 6 months. <h3>Conclusions</h3> The responsiveness of US disease activities is considered to predict further clinical response in patients with RA treated by biologic DMARDs. In addition, the evaluation of wrist and MCP joints by PD may be more useful to monitor the disease activities of these patients. <h3>References</h3> Kawashiri SY, et al. Ultrasonographic examination of rheumatoid arthritis patients who are free of physical synovitis: power Doppler subclinical synovitis is associated with bone erosion. Rheumatology (Oxford). In press. Kawashiri SY, et al. The power Doppler ultrasonography score from 24 synovial sites or 6 simplified synovial sites, including the metacarpophalangeal joints, reflects the clinical disease activity and level of serum biomarkers in patients with rheumatoid arthritis. Rheumatology (Oxford) 2011; 50: 962-5. <h3>Acknowledgements</h3> n.p. <h3>Disclosure of Interest</h3> None declared <h3>DOI</h3> 10.1136/annrheumdis-2014-eular.2574" @default.
• W2331765972 created "2016-06-24" @default.
• W2331765972 creator A5019615899 @default.
• W2331765972 creator A5019895856 @default.
• W2331765972 creator A5022076444 @default.
• W2331765972 creator A5024788322 @default.
• W2331765972 creator A5034473077 @default.
• W2331765972 creator A5035694731 @default.
• W2331765972 creator A5035859888 @default.
• W2331765972 creator A5037317578 @default.
• W2331765972 creator A5042469555 @default.
• W2331765972 creator A5044442302 @default.
• W2331765972 creator A5050952866 @default.
• W2331765972 creator A5070326257 @default.
• W2331765972 creator A5073616055 @default.
• W2331765972 creator A5086343918 @default.
• W2331765972 creator A5089657463 @default.
• W2331765972 date "2014-06-01" @default.
• W2331765972 modified "2023-09-26" @default.
• W2331765972 title "SAT0215 Ultrasound Disease Activity at 3 Months Predicts the Clinical Response at 6 Months of Patients with Rheumatoid Arthritis Treated by Biologic Disease Modifying Anti-Rheumatic Drugs" @default.
• W2331765972 doi "https://doi.org/10.1136/annrheumdis-2014-eular.2574" @default.
• W2331765972 hasPublicationYear "2014" @default.
• W2331765972 type Work @default.
• W2331765972 sameAs 2331765972 @default.
• W2331765972 citedByCount "0" @default.
• W2331765972 crossrefType "journal-article" @default.
• W2331765972 hasAuthorship W2331765972A5019615899 @default.
• W2331765972 hasAuthorship W2331765972A5019895856 @default.
• W2331765972 hasAuthorship W2331765972A5022076444 @default.
• W2331765972 hasAuthorship W2331765972A5024788322 @default.
• W2331765972 hasAuthorship W2331765972A5034473077 @default.
• W2331765972 hasAuthorship W2331765972A5035694731 @default.
• W2331765972 hasAuthorship W2331765972A5035859888 @default.
• W2331765972 hasAuthorship W2331765972A5037317578 @default.
• W2331765972 hasAuthorship W2331765972A5042469555 @default.
• W2331765972 hasAuthorship W2331765972A5044442302 @default.
• W2331765972 hasAuthorship W2331765972A5050952866 @default.
• W2331765972 hasAuthorship W2331765972A5070326257 @default.
• W2331765972 hasAuthorship W2331765972A5073616055 @default.
• W2331765972 hasAuthorship W2331765972A5086343918 @default.
• W2331765972 hasAuthorship W2331765972A5089657463 @default.
• W2331765972 hasConcept C126322002 @default.
• W2331765972 hasConcept C141071460 @default.
• W2331765972 hasConcept C198451711 @default.
• W2331765972 hasConcept C2777077863 @default.
• W2331765972 hasConcept C2777575956 @default.
• W2331765972 hasConcept C2779134260 @default.
• W2331765972 hasConcept C2779244835 @default.
• W2331765972 hasConcept C2909338845 @default.
• W2331765972 hasConcept C71924100 @default.
• W2331765972 hasConceptScore W2331765972C126322002 @default.
• W2331765972 hasConceptScore W2331765972C141071460 @default.
• W2331765972 hasConceptScore W2331765972C198451711 @default.
• W2331765972 hasConceptScore W2331765972C2777077863 @default.
• W2331765972 hasConceptScore W2331765972C2777575956 @default.
• W2331765972 hasConceptScore W2331765972C2779134260 @default.
• W2331765972 hasConceptScore W2331765972C2779244835 @default.
• W2331765972 hasConceptScore W2331765972C2909338845 @default.
• W2331765972 hasConceptScore W2331765972C71924100 @default.
• W2331765972 hasIssue "Suppl 2" @default.
• W2331765972 hasLocation W23317659721 @default.
• W2331765972 hasOpenAccess W2331765972 @default.
• W2331765972 hasPrimaryLocation W23317659721 @default.
• W2331765972 hasRelatedWork W1586489203 @default.
• W2331765972 hasRelatedWork W2086657643 @default.
• W2331765972 hasRelatedWork W2104646232 @default.
• W2331765972 hasRelatedWork W2313178064 @default.
• W2331765972 hasRelatedWork W2409257764 @default.
• W2331765972 hasRelatedWork W2410978906 @default.
• W2331765972 hasRelatedWork W2800677832 @default.
• W2331765972 hasRelatedWork W2925118230 @default.
• W2331765972 hasRelatedWork W2954732647 @default.
• W2331765972 hasRelatedWork W2006437879 @default.
• W2331765972 hasVolume "73" @default.
• W2331765972 isParatext "false" @default.
• W2331765972 isRetracted "false" @default.
• W2331765972 magId "2331765972" @default.
• W2331765972 workType "article" @default.